Stay updated on Iberdomide Combo with Elotuzumab in Myeloma Clinical Trial
Sign up to get notified when there's something new on the Iberdomide Combo with Elotuzumab in Myeloma Clinical Trial page.

Latest updates to the Iberdomide Combo with Elotuzumab in Myeloma Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedA new revision entry v3.5.4 was added to the Record History, and the previous revision label v3.5.3 was removed from the visible changes.SummaryDifference0.1%

- Check25 days agoNo Change Detected
- Check39 days agoChange DetectedThe page’s footer revision indicator was updated from v3.5.2 to v3.5.3, reflecting a system/site version change rather than a change to the clinical trial record itself.SummaryDifference0.1%

- Check47 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0 from the study history page.SummaryDifference0.1%

- Check75 days agoChange DetectedAdded revision v3.5.0 to the history and removed revision v3.4.3.SummaryDifference0.1%

- Check83 days agoChange DetectedAdded Revision: v3.4.3 to the record history and removed Revision: v3.4.2.SummaryDifference0.1%

- Check111 days agoChange DetectedThe page history shows a new revision tag (v3.4.2) and the removal of a prior government funding status notice, which do not affect study data or user-facing functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

Stay in the know with updates to Iberdomide Combo with Elotuzumab in Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Iberdomide Combo with Elotuzumab in Myeloma Clinical Trial page.